These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 32125488

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: effects of heart failure and angiotensin-converting enzyme inhibitor treatment.
    Kelly MP, Kahr O, Aalkjaer C, Cumin F, Samani NJ.
    Clin Sci (Lond); 1997 May; 92(5):455-65. PubMed ID: 9176018
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats.
    Pan Y, Zhu W, Ma J, Xin P, Han B, He Y, Wang Y, Peng T, Wei M.
    Arch Cardiovasc Dis; 2011 Jan; 104(1):17-28. PubMed ID: 21276574
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
    Gao XM, Tsai A, Al-Sharea A, Su Y, Moore S, Han LP, Kiriazis H, Dart AM, Murphy AJ, Du XJ.
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):145-156. PubMed ID: 28204966
    [Abstract] [Full Text] [Related]

  • 28. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, Roman M, Ramirez C, Copaja M, Diaz-Araya G, Castro P, Lavandero S.
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [Abstract] [Full Text] [Related]

  • 29. Enalapril improves arterial elastic properties in rats with myocardial infarction.
    Ben Driss A, Himbert C, Poitevin P, Duriez M, Michel JB, Levy BI.
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):102-7. PubMed ID: 10413075
    [Abstract] [Full Text] [Related]

  • 30. Beneficial effects of therapy on the progression of structural remodeling during healing after reperfused and nonreperfused myocardial infarction: different effects on different parameters.
    Jugdutt BI, Menon V.
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):95-107. PubMed ID: 12075398
    [Abstract] [Full Text] [Related]

  • 31. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K, Gaudron P, Anders HJ, Weidemann F, Turschner O, Nahrendorf M, Ertl G.
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [Abstract] [Full Text] [Related]

  • 32. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
    Badae NM, El Naggar AS, El Sayed SM.
    Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489
    [Abstract] [Full Text] [Related]

  • 33. Effects of amlodipine versus enalapril on left ventricular remodelling after reperfused anterior myocardial canine infarction.
    Jugdutt BI.
    Can J Cardiol; 1997 Oct; 13(10):945-54. PubMed ID: 9374951
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction: a possible mechanism of prevention of cardiac events by angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk myocardial infarction.
    Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, Iida K, Matsumoto M, Kumabe N, Onikura M, Hirayama A.
    Intern Med; 2009 Oct; 48(11):877-82. PubMed ID: 19483355
    [Abstract] [Full Text] [Related]

  • 36. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH, Xu J, Yang XP, Yang F, Shesely E, Carretero OA.
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [Abstract] [Full Text] [Related]

  • 37. Increased survival in rats with congestive heart failure treated with enalapril.
    Sweet CS, Emmert SE, Stabilito II, Ribeiro LG.
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):636-42. PubMed ID: 2450232
    [Abstract] [Full Text] [Related]

  • 38. 11C-DPA-713 Versus 18F-GE-180: A Preclinical Comparison of Translocator Protein 18 kDa PET Tracers to Visualize Acute and Chronic Neuroinflammation in a Mouse Model of Ischemic Stroke.
    Chaney A, Cropper HC, Johnson EM, Lechtenberg KJ, Peterson TC, Stevens MY, Buckwalter MS, James ML.
    J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695
    [Abstract] [Full Text] [Related]

  • 39. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats.
    Sunagawa Y, Morimoto T, Wada H, Takaya T, Katanasaka Y, Kawamura T, Yanagi S, Marui A, Sakata R, Shimatsu A, Kimura T, Kakeya H, Fujita M, Hasegawa K.
    Circ J; 2011 Jan; 75(9):2151-9. PubMed ID: 21737953
    [Abstract] [Full Text] [Related]

  • 40. [The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].
    Kardiologiia; 2008 Jan; 48(11):64-8. PubMed ID: 19076083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.